Paper2946973
The topography of plaques and tangles in Down's syndrome patients of different ages.
Mann DM and 3 others. Neuropathol Appl Neurobiol, 1986. Cited by 136 papers, by iCite.
Cite this record
ConductScience Library. The topography of plaques and tangles in Down's syndrome patients of different ages. Papers, record 2946973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2946973
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Down Syndrome | Major topic |
| Neurofibrils | Major topic |
| Adult | |
| Age Factors | |
| Aged | |
| Alzheimer Disease | |
| Amygdala | |
| Female | |
| Hippocampus | |
| Humans | |
| Limbic System | |
| Male | |
| Middle Aged |
Source PubMed
Cited by50
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42301522 | Neuropathological study of the effects of aducanumab anti-Aβ immunotherapy on patients with Alzheimer's disease. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/42301522 | PubMed |
| 39834700 | Feasibility and potential diagnostic value of [18F]PI-2620 PET in patients with down syndrome and Alzheimer's disease: a case series. | Front Neurosci | 2024 | https://conductscience.org/library/papers/39834700 | PubMed |
| 39605035 | Down syndrome frontal cortex layer III and layer V pyramidal neurons exhibit lamina specific degeneration in aged individuals. | Acta Neuropathol Commun | 2024 | https://conductscience.org/library/papers/39605035 | PubMed |
| 39105932 | Analysis of microisolated frontal cortex excitatory layer III and V pyramidal neurons reveals a neurodegenerative phenotype in individuals with Down syndrome. | Acta Neuropathol | 2024 | https://conductscience.org/library/papers/39105932 | PubMed |
| 39031371 | Hippocampal CA1 Pyramidal Neurons Display Sublayer and Circuitry Dependent Degenerative Expression Profiles in Aged Female Down Syndrome Mice. | J Alzheimers Dis | 2024 | https://conductscience.org/library/papers/39031371 | PubMed |
| 38867338 | Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold. | Acta Neuropathol Commun | 2024 | https://conductscience.org/library/papers/38867338 | PubMed |
| 38012338 | Human cystatin C induces the disaggregation process of selected amyloid beta peptides: a structural and kinetic view. | Sci Rep | 2023 | https://conductscience.org/library/papers/38012338 | PubMed |
| 37191946 | Basal forebrain cholinergic neurons are vulnerable in a mouse model of Down syndrome and their molecular fingerprint is rescued by maternal choline supplementation. | FASEB J | 2023 | https://conductscience.org/library/papers/37191946 | PubMed |
| 36394661 | RNAseq analysis of olfactory neuroepithelium cytological samples in individuals with Down syndrome compared to euploid controls: a pilot study. | Neurol Sci | 2023 | https://conductscience.org/library/papers/36394661 | PubMed |
| 35964542 | Amyloid- β and tau deposition influences cognitive and functional decline in Down syndrome. | Neurobiol Aging | 2022 | https://conductscience.org/library/papers/35964542 | PubMed |
| 35532913 | Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial. | JAMA Neurol | 2022 | https://conductscience.org/library/papers/35532913 | PubMed |
| 34690739 | Maternal Choline Supplementation as a Potential Therapy for Down Syndrome: Assessment of Effects Throughout the Lifespan. | Front Aging Neurosci | 2021 | https://conductscience.org/library/papers/34690739 | PubMed |
| 34682809 | Aging with Down Syndrome-Where Are We Now and Where Are We Going? | J Clin Med | 2021 | https://conductscience.org/library/papers/34682809 | PubMed |
| 34362198 | Postnatal Cytoarchitecture and Neurochemical Hippocampal Dysfunction in Down Syndrome. | J Clin Med | 2021 | https://conductscience.org/library/papers/34362198 | PubMed |
| 34263425 | Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease. | Mol Neurobiol | 2021 | https://conductscience.org/library/papers/34263425 | PubMed |
| 33670211 | Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules. | Biomolecules | 2021 | https://conductscience.org/library/papers/33670211 | PubMed |
| 31379087 | Neuropathological correlates of amyloid PET imaging in Down syndrome. | Dev Neurobiol | 2019 | https://conductscience.org/library/papers/31379087 | PubMed |
| 31180719 | Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease. | FASEB J | 2019 | https://conductscience.org/library/papers/31180719 | PubMed |
| 30734106 | Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia. | Acta Neuropathol | 2019 | https://conductscience.org/library/papers/30734106 | PubMed |
| 29394516 | CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation. | Hippocampus | 2018 | https://conductscience.org/library/papers/29394516 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2946973
GET https://conductscience.org/api/papers/v1/2946973/cited_by?page=2